PBYI
Puma Biotechnology Inc
$4.46
+$0.04(+0.90%)
49
Overall
80
Value
18
Tech
--
Quality
Market Cap
$227.68M
Volume
398.01K
52W Range
$2.32 - $6.07
Target Price
$3.00
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | -- | -- | $27.7M | $251.0M | $272.3M | $225.1M | $253.2M | $228.0M | $235.6M | $230.5M | ||
| Total Revenue | -- | -- | $27.7M | $251.0M | $272.3M | $225.1M | $253.2M | $228.0M | $235.6M | $230.5M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | -- | $-5.6M | $34.6M | -- | $39.4M | $63.7M | $55.1M | $62.7M | $64.4M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | -- | -- | $22.1M | $251.0M | $272.3M | $185.7M | $189.5M | $172.9M | $173.0M | $166.1M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-240.3M | $-276.6M | $-320.1M | $345.7M | $311.3M | $216.1M | $188.2M | $142.2M | $140.3M | $135.1M | ||
| Research & Development | $208.5M | $222.8M | $207.8M | $164.9M | $132.9M | $97.7M | $71.9M | $52.2M | $50.4M | $54.9M | ||
| Research Expense | $208.5M | $222.8M | $207.8M | $164.9M | $132.9M | $97.7M | $71.9M | $52.2M | $50.4M | $54.9M | ||
| Selling, General & Administrative | $31.8M | $53.8M | $106.7M | $146.2M | $141.6M | $118.5M | $116.3M | $90.0M | $89.9M | $80.2M | ||
| Selling & Marketing Expenses | -- | $53.8M | $106.7M | -- | -- | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $31.8M | $53.8M | $-3.9M | $146.2M | $141.6M | $118.5M | $116.3M | $90.0M | $89.9M | $80.2M | ||
| Salaries & Wages | -- | -- | -- | $-86.9M | $57.3M | -- | -- | $11.8M | $10.2M | $8.2M | ||
| Depreciation & Amortization | -- | -- | -- | $-1.1M | $900.0K | $900.0K | $700.0K | $600.0K | $400.0K | $400.0K | ||
| Depreciation & Amortization | -- | -- | -- | $-1.1M | $900.0K | $900.0K | $700.0K | $600.0K | $400.0K | $400.0K | ||
| Amortization | -- | -- | $-1.6M | $-3.9M | $5.4M | $8.3M | $10.6M | $9.2M | $9.7M | $9.7M | ||
| Other Operating Expenses | $-2.0M | $-840.0K | $-1.8M | $34.6M | $-36.8M | $-1.3M | $-985.0K | $-374.0K | $-452.0K | $-400.0K | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-240.3M | $-276.6M | $-292.4M | $-94.7M | $-39.0M | $-30.4M | $1.3M | $23.7M | $32.6M | $31.0M | ||
| EBITDA | $-238.3M | $-271.9M | $-288.4M | $-95.2M | $-52.4M | $-35.7M | $-4.7M | $21.9M | $34.2M | $35.6M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | $720.0K | $11.0M | $15.0M | $14.0M | $12.8M | $11.6M | $13.3M | -- | ||
| Intinc | $971.0K | $958.0K | $1.3M | $1.8M | $2.8M | $489.0K | $160.0K | $813.0K | $2.6M | $4.7M | ||
| Net Non-Operating Interest Income/Expense | $971.0K | $958.0K | $536.0K | $-9.2M | $-12.2M | $-13.6M | $-12.6M | $-10.8M | $2.6M | $4.7M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | $-8.1M | -- | $-8.1M | -- | -- | -- | ||
| Other Income/Expense | $-25.0K | $373.0K | $101.0K | $9.7M | $24.3M | $15.8M | $17.4M | $-19.5M | $-759.0K | $-862.0K | ||
| Other Special Charges | $25.0K | $-373.0K | $-101.0K | $-9.7M | $-16.2M | $-15.8M | $-9.3M | $-28.0K | $759.0K | $862.0K | ||
| SPECIAL ITEMS | ||||||||||||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-239.3M | $-276.0M | $-291.2M | $-102.6M | $-60.5M | $-45.7M | $-16.0M | $12.0M | $22.7M | $24.1M | ||
| Pre-Tax Income | $-239.3M | $-276.0M | $-292.0M | $-113.6M | $-75.5M | $-59.8M | $-28.8M | $457.0K | $22.7M | $24.1M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-4.2M | $-6.2M | $-141.1M | $-10.9M | $53.0K | $207.0K | $324.0K | $455.0K | $1.1M | $-6.2M | ||
| NET INCOME | ||||||||||||
| Net Income | $-239.3M | $-276.0M | $-292.0M | $-113.6M | $-75.6M | $-60.0M | $-29.1M | $2.0K | $21.6M | $30.3M | ||
| Net Income (Continuing Operations) | $-239.3M | $-276.0M | $-292.0M | $-113.6M | $-75.6M | $-60.0M | $-29.1M | $2.0K | $21.6M | $30.3M | ||
| Net Income (Discontinued Operations) | $-239.3M | $-276.0M | $-292.0M | $-113.6M | $-75.6M | $-60.0M | $-29.1M | $2.0K | $21.6M | $30.3M | ||
| Net Income (Common Stockholders) | $-239.3M | $-276.0M | $-292.0M | $-113.6M | $-75.6M | $-60.0M | $-29.1M | $2.0K | $21.6M | $30.3M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $17.9M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-240.3M | $-276.6M | $-325.6M | $345.7M | $311.3M | $255.5M | $251.9M | $197.3M | $203.0M | $199.5M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $32.1M | $33.3M | $37.2M | $37.9M | $38.8M | $39.6M | $40.6M | $44.7M | $47.1M | $48.6M | ||
| Average Shares Outstanding (Diluted) | $32.1M | $33.3M | $37.2M | $37.9M | $38.8M | $39.6M | $40.6M | $44.9M | $47.6M | $49.1M | ||
| Shares Outstanding | $32.5M | $37.0M | $37.7M | $38.5M | $39.3M | $40.3M | $41.3M | $46.6M | $50.4M | $49.6M | ||
| Basic EPS | -- | -- | -- | $-2.99 | $-1.95 | $-1.52 | $-0.72 | -- | $0.46 | $0.62 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $-2.99 | $-1.95 | $-1.52 | $-0.72 | -- | $0.46 | $0.62 | ||
| Diluted EPS | $-7.45 | $-8.29 | $-7.85 | $-2.99 | $-1.95 | $-1.52 | $-0.72 | -- | $0.45 | $0.62 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $-0.72 | -- | $0.45 | $0.62 | ||
| OTHER METRICS | ||||||||||||
| Other Gand A | $31.8M | $53.8M | $-3.9M | $146.2M | $141.6M | $118.5M | $116.3M | $90.0M | $89.9M | $80.2M | ||
| Other Write Off | -- | -- | -- | -- | -- | -- | $-1.0M | -- | -- | -- | ||
| Rent And Landing Fees | $31.8M | $53.8M | $-3.9M | $-4.7M | $4.7M | -- | -- | -- | -- | -- | ||
| Selling Expense | -- | $53.8M | $106.7M | -- | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PBYI | $4.46 | +0.9% | 398.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |